Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 565 shares at $2.95 ($2K) on 2018-06-15, disclosed to the SEC on 2018-06-20.
Open-market sale of $2k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2018-08-15 | $306K | — | Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-13 | $546K | — | Filing → |